91 related articles for article (PubMed ID: 890692)
1. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
[TBL] [Abstract][Full Text] [Related]
2. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
3. cis-Dichlorodiammineplatinum (II) in advanced osteogenic sarcoma.
Ochs JJ; Freeman AI; Douglass HO; Higby DS; Mindell ER; Sinks LF
Cancer Treat Rep; 1978 Feb; 62(2):239-45. PubMed ID: 346212
[TBL] [Abstract][Full Text] [Related]
4. cis-Dichlorodiammineplatinum(II) in childhood cancer.
Freeman AI; Ettinger LJ; Brecher ML
Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
[TBL] [Abstract][Full Text] [Related]
5. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
Salem P; Hall SW; Benjamin RS; Murphy WK; Wharton JT; Bodey GP
Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cis-dichlorodiammineplatinum(II) in children with advanced malignant diseases: Southwest Oncology Group Studies.
Vietti TJ; Nitschke R; Starling KA; van Eys J
Cancer Treat Rep; 1979; 63(9-10):1611-4. PubMed ID: 291482
[TBL] [Abstract][Full Text] [Related]
7. [Effects of cis-DDP in children with refractory malignant tumors].
Nakadate H; Kobayashi R; Nishi M; Hatae Y; Takeda T; Uchino J; Hirama T; Kobayashi H
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):598-603. PubMed ID: 3954383
[TBL] [Abstract][Full Text] [Related]
8. [Effect of cis-platinum in neuroblastoma].
Nakadate H; Nishi M; Hattori T; Hatae Y; Takeda T
Gan To Kagaku Ryoho; 1985 Jan; 12(1):147-50. PubMed ID: 4038446
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of cisplatin in children with malignant solid tumors: a phase II study.
Pratt CB; Hayes A; Green AA; Evans WE; Senzer N; Howarth CB; Ransom JL; Crom W
Cancer Treat Rep; 1981; 65(11-12):1021-6. PubMed ID: 7197583
[TBL] [Abstract][Full Text] [Related]
11. Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
Baum ES; Gaynon P; Greenberg L; Krivit W; Hammond D
Cancer Treat Rep; 1981; 65(9-10):815-22. PubMed ID: 6944156
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of high-dose cis-dichlorodiammineplatinum(II) with forced diuresis.
Chary KK; Higby DJ; Henderson ES; Swinerton KD
Cancer Treat Rep; 1977; 61(3):367-70. PubMed ID: 266972
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
Wiltshaw E; Kroner T
Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
[TBL] [Abstract][Full Text] [Related]
14. Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Blaney SM; Needle MN; Gillespie A; Sato JK; Reaman GH; Berg SL; Adamson PC; Krailo MD; Bleyer WA; Poplack DG; Balis FM
Clin Cancer Res; 1998 Feb; 4(2):357-60. PubMed ID: 9516923
[TBL] [Abstract][Full Text] [Related]
15. [Phase I study of a new antineoplastic agent, cis-diamminedichloroplatinum (II)].
Gan To Kagaku Ryoho; 1982 Jan; 9(1):38-45. PubMed ID: 6892190
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of carboplatin (CBDCA) in children with cancer.
Bacha DM; Caparros-Sison B; Allen JA; Walker R; Tan CT
Cancer Treat Rep; 1986 Jul; 70(7):865-9. PubMed ID: 3521846
[TBL] [Abstract][Full Text] [Related]
17. [Phase II study of cis-dichlorodiammineplatinum (II) for non-small cell lung cancer].
Fukuoka M; Furuse K; Takada M; Negoro S; Tamai S; Matsui K; Sakai N; Ryu S; Yoshinaga T; Kawahara M
Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):471-8. PubMed ID: 2988455
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
Yap HY; Salem P; Hortobagyi GN; Bodey GP; Buzdar AU; Tashima CK; Blumenschein GR
Cancer Treat Rep; 1978 Mar; 62(3):405-8. PubMed ID: 348308
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
Recchia F; Sica G; De Filippis S; Rosselli M; Saggio G; Guerriero G; Pompili P; Rea S
Anticancer Res; 2000; 20(3B):1985-90. PubMed ID: 10928138
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study.
Rossof AH; Coltman CA; Jones SE; Talley RW
Cancer Treat Rep; 1979; 63(9-10):1605-8. PubMed ID: 498159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
